Literature DB >> 6826228

Interactions of mineralocorticoids and pressor agents in vascular smooth muscle.

M A Weber, R E Purdy, J I Drayer.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6826228     DOI： 10.1161/01.hyp.5.2_pt_2.i41

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

Review 1.  Spironolactone in congestive heart failure.

Authors:  J E Soberman; K T Weber
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone.

Authors:  N Muñoz-Durango; A Vecchiola; L M Gonzalez-Gomez; F Simon; C A Riedel; C E Fardella; A M Kalergis
Journal:  Biomed Res Int       Date:  2015-09-10       Impact factor: 3.411

3.  A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure.

Authors:  A Shehab; A A Elnour; A D Struthers
Journal:  Cardiovasc J Afr       Date:  2008 Nov-Dec       Impact factor: 1.167

4.  A common molecular motif characterizes extracellular allosteric enhancers of GPCR aminergic receptors and suggests enhancer mechanism of action.

Authors:  Robert Root-Bernstein; Patrick F Dillon
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.